Zobrazeno 1 - 10
of 55
pro vyhledávání: '"James L. Lordan"'
Autor:
Andrew J. Peacock, Yi Ling, Martin K. Johnson, David G. Kiely, Robin Condliffe, Charlie A. Elliot, J. Simon R. Gibbs, Luke S. Howard, Joanna Pepke-Zaba, Karen K.K. Sheares, Paul A. Corris, Andrew J. Fisher, James L. Lordan, Sean Gaine, J. Gerry Coghlan, S. John Wort, Michael A. Gatzoulis
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Patients classified as idiopathic pulmonary arterial hypertension (defined as Group 1 on European Respiratory Society (ERS)/European Cardiac Society (ESC) criteria) may have evidence of minor co-existing lung disease on thoracic computed tomography.
Externí odkaz:
https://doaj.org/article/706f765a1ce94cf38464ec652442ad0a
Autor:
Eleanor Morris, Stephen J Wort, Martin K Johnson, James L Lordan, Daniel S Knight, Chloe Roddis, Charlotte Durrington, Harrison D Stubbs, John Cannon, Emily Knightbridge, Wendy Gin-Sing, Fiona Massey, Ruta Virsinskaite, Eleanor Sear, Joy Apple-Pinguel
Publikováno v:
BMJ Open Respiratory Research, Vol 11, Iss 1 (2024)
Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker of cardiac ventricular wall stress that is incorporated into pulmonary hypertension (PH) risk stratification models. Sendaway sampling may enable patients to perform NT-p
Externí odkaz:
https://doaj.org/article/5f8e7e97c9144b448b038006bd128d62
Autor:
Helmy Haja Mydin, Paul A. Corris, Audrey Nicholson, John D. Perry, Gerard Meachery, Emma C. L. Marrs, Steven Peart, Christine Fagan, James L. Lordan, Andrew J. Fisher, Frances K. Gould
Publikováno v:
Journal of Transplantation, Vol 2012 (2012)
Early infection is a recognised complication after lung transplantation in patients with cystic fibrosis (CF). Our centre uses multiple combination bactericidal testing (MCBT) when determining appropriate peritransplant prophylactic regimens. To eval
Externí odkaz:
https://doaj.org/article/c99bc6dba9c84d3689f05d8792cfa9e8
Publikováno v:
BMJ Open Respiratory Research, Vol 10, Iss 1 (2023)
Background Interstitial lung disease (ILD) has emerged as the most common indication for lung transplantation globally. However, post-transplant survival varies depending on the underlying disease phenotype and comorbidities. This study aimed to desc
Externí odkaz:
https://doaj.org/article/d47d98e8d6ba44b0b48ada509140d051
Publikováno v:
BMJ Open Respiratory Research. 10:e001387
BackgroundInterstitial lung disease (ILD) has emerged as the most common indication for lung transplantation globally. However, post-transplant survival varies depending on the underlying disease phenotype and comorbidities. This study aimed to descr
Autor:
John Busby, Peter Bradding, Cecile T.J. Holweg, John G. Matthews, Rekha Chaudhuri, Liam G Heaney, Akiko Chai, Tracy Staton, Robert Niven, Fang Cai, Andrew Menzies-Gow, James L. Lordan, Adel H. Mansur
Publikováno v:
Busby, J, Holweg, C, Chai, A, Bradding, P, Cai, F, Chaudhuri, R, Mansur, A, Lordan, J, Matthews, J G, Menzies-Gow, A, Niven, R, Staton, T, Heaney, L G & Medical Research Council UK Refractory Asthma Stratification Programme (RASP-UK) 2019, ' Change in type-2 biomarkers and related cytokines with prednisolone in uncontrolled severe oral corticosteroid dependent asthmatics: an interventional open-label study ', Thorax, vol. 74, no. 8, pp. 806-809 . https://doi.org/10.1136/thoraxjnl-2018-212709
Type-2 biomarkers and related cytokines (IL-5, IL-13), lung function and asthma symptoms were measured in 44 poorly-controlled severe oral corticosteroid (OCS)-dependent asthmatics for up to 88 days after a 7-day prednisolone boost (0.5 mg/kg). High-
Autor:
Colm McCabe, Anna Reed, Susanna Price, Aimee Brame, Benjamin Garfield, Robin Condliffe, Thomas Pickworth, Luke Howard, David M. Alexander, Sean Gaine, TC Aw, Guillermo Martinez, S. Kemp, Benjamin E. Schreiber, Davina Wong, Denny Z. H. Levett, Chinthaka B Samaranayake, Carl Harries, Martin Johnson, Dolores Taboada, Bhashkar Mukherjee, David G. Kiely, Gerry Coghlan, Philip Marino, Stephen J. Wort, Laura C. Price, James L. Lordan, Konstantinos Dimopoulos, Stephane Ledot, Colin Church, Rachel J. Davies, Aleksander Kempny, Michael A. Gatzoulis, Andrew Curry
Publikováno v:
British journal of anaesthesia. 126(4)
Background The risk of complications, including death, is substantially increased in patients with pulmonary hypertension (PH) undergoing anaesthesia for surgical procedures, especially in those with pulmonary arterial hypertension (PAH) and chronic
Autor:
Allan Lawrie, Luke Howard, Gerry Coghlan, Martin R. Wilkins, Nicholas W. Morrell, David G. Kiely, Martin Johnson, Eleni Sofianopoulou, SJ Wort, Mark Toshner, James L. Lordan, Colin Church
Publikováno v:
The European Respiratory Journal
article-version (VoR) Version of Record
article-version (VoR) Version of Record
In this journal, Pellino et al. [1] presented a survival analysis to assess how deprivation affects prognosis in patients with pulmonary arterial hypertension (PAH). Their conclusions were that social deprivation is not a significant referral barrier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d63ef6ffea062c92ff9b7eadec457063
Autor:
Luke S. Howard, Michael A. Gatzoulis, Karen Sheares, James L. Lordan, S. John Wort, Joanna Pepke-Zaba, Andrew J. Peacock, J. Gerry Coghlan, Andrew J. Fisher, Paul A. Corris, Robin Condliffe, Charlie Elliot, Yi Ling, J. Simon R. Gibbs, Sean Gaine, David G. Kiely, Martin Johnson
Publikováno v:
Pulmonary Circulation, Vol 10 (2020)
Pulmonary Circulation
Pulmonary Circulation
Patients classified as idiopathic pulmonary arterial hypertension (defined as Group 1 on European Respiratory Society (ERS)/European Cardiac Society (ESC) criteria) may have evidence of minor co-existing lung disease on thoracic computed tomography.